PRIMECAP Management acquired 18.1M AstraZeneca PLC shares worth $3.44B. That's 2.06% of their equity portfolio (9th largest holding). The investor owns 1.17% of the outstanding AstraZeneca PLC stock. PRIMECAP Management started to build up the position in AstraZeneca PLC in Q1 2026. Since then they sold 119k shares. The investor's estimated purchase price is $3.46B, resulting in a loss of 0.5%.